First trimester development of the human nigrostriatal dopamine system - PubMed (original) (raw)
First trimester development of the human nigrostriatal dopamine system
P M Almqvist et al. Exp Neurol. 1996 Jun.
Abstract
The aim of the present study was to characterize the morphological and neurochemical differentiation of mesencephalic dopaminergic neurons in human embryos, derived from elective first trimester abortions. Embryonic brain tissue was taken for analysis of tyrosine hydroxylase (TH) by immunohistochemistry and Western blot, and for analysis of endogenous dopamine (A) content using HPLC-ED. TH expression was first detected at 3.5 weeks of gestational age (Carnegie stage 11) by immunohistochemical staining of the primordial sympathetic trunk along both sides of the neural tube. In sagittal sections of the intact 4.5-week-old embryo, a small, distinct population of rounded, densely packed TH-immunoreactive perikarya with short primary processes was seen in the midbrain. During the latter half of the first trimester, the number of TH-stained cells as well as the length and number of axonal processes projecting toward and into the developing neostriatum increased rapidly. At the end of the first trimester, varicose fibers could be detected in the striatal anlage. In order to verify that TH was the antigen recognized by the antibodies used for immunohistochemistry on human tissue specimens, mesencephalic tissue of 5-10 weeks gestation was analyzed by Western blot technique. A single, homogeneous band with the apparent molecular weight of approximately 60 kDa was clearly detected at 5 weeks of age. The amount of TH/mg total protein increased at least 10-fold between 5-10 weeks of gestation. For comparison, the mesencephalon and the forebrain/basal ganglia were analyzed for endogenous DA content using HPLC-ED. DA was first detected at 5.5 weeks of gestational age in both mid- and forebrain, and DA levels were found to increase exponentially from 7 to 7.5 weeks of age, reaching 4-5.5 ng DA/mesencephalon and 50-75 ng DA/g caudate nucleus-putamen anlage at the end of the first trimester. Together, morphological and biochemical data presented here constitute evidence for a very early appearance, migration, and differentiation as well as functional development of human mesencephalic dopaminergic neurons and their projections into target areas during the first trimester.
Similar articles
- Development of the catecholamine neurons in human embryos and fetuses, with special emphasis on the innervation of the cerebral cortex.
Zecevic N, Verney C. Zecevic N, et al. J Comp Neurol. 1995 Jan 23;351(4):509-35. doi: 10.1002/cne.903510404. J Comp Neurol. 1995. PMID: 7721981 - Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
Ostergaard K, Jones SA, Hyman C, Zimmer J. Ostergaard K, et al. Exp Neurol. 1996 Dec;142(2):340-50. doi: 10.1006/exnr.1996.0203. Exp Neurol. 1996. PMID: 8934565 - Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
Dal Bo G, Bérubé-Carrière N, Mendez JA, Leo D, Riad M, Descarries L, Lévesque D, Trudeau LE. Dal Bo G, et al. Neuroscience. 2008 Sep 22;156(1):59-70. doi: 10.1016/j.neuroscience.2008.07.032. Epub 2008 Jul 25. Neuroscience. 2008. PMID: 18706980 - [Atlas of the stages of development of the nervous system in the intact human embryo].
O'Rahilly R, Muller F, Bossy J. O'Rahilly R, et al. Arch Anat Histol Embryol. 1982;65:57-76. Arch Anat Histol Embryol. 1982. PMID: 6764349 Review. French. - [Development of human hypothalamus at the end of the first and in the second trimester of gestation].
Babović SS, Srdić B, Mijatov-Ukropina L, Stojsić-Dzunja L. Babović SS, et al. Med Pregl. 2005 Jan-Feb;58(1-2):37-42. doi: 10.2298/mpns0502037b. Med Pregl. 2005. PMID: 18257203 Review. Serbian.
Cited by
- Characterization of Porcine Ventral Mesencephalic Precursor Cells following Long-Term Propagation in 3D Culture.
Jensen PS, Lyck L, Jensen P, Zimmer J, Meyer M. Jensen PS, et al. Stem Cells Int. 2012;2012:761843. doi: 10.1155/2012/761843. Epub 2012 Nov 20. Stem Cells Int. 2012. PMID: 23258982 Free PMC article. - Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities.
Kim TW, Koo SY, Studer L. Kim TW, et al. Front Cell Dev Biol. 2020 Aug 6;8:729. doi: 10.3389/fcell.2020.00729. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32903681 Free PMC article. Review. - Preclinical Analysis of Fetal Human Mesencephalic Neural Progenitor Cell Lines: Characterization and Safety In Vitro and In Vivo.
Moon J, Schwarz SC, Lee HS, Kang JM, Lee YE, Kim B, Sung MY, Höglinger G, Wegner F, Kim JS, Chung HM, Chang SW, Cha KY, Kim KS, Schwarz J. Moon J, et al. Stem Cells Transl Med. 2017 Feb;6(2):576-588. doi: 10.5966/sctm.2015-0228. Epub 2016 Sep 2. Stem Cells Transl Med. 2017. PMID: 28191758 Free PMC article. - Maternal vitamin D status during pregnancy and offspring risk of childhood/adolescent depression: Results from the Avon Longitudinal Study of Parents and Children (ALSPAC).
Wang MJ, Dunn EC, Okereke OI, Kraft P, Zhu Y, Smoller JW. Wang MJ, et al. J Affect Disord. 2020 Mar 15;265:255-262. doi: 10.1016/j.jad.2020.01.005. Epub 2020 Jan 7. J Affect Disord. 2020. PMID: 32090749 Free PMC article. - Correspondence on "Recognition and Management of Delirium in the Neonatal Intensive Care Unit: Case Series From a Single-Center Level IV Intensive Care Unit".
Chavez-Valdez R, Northington FJ, Sharp A, Burton VJ, Lammert DB, Jantzie LL, Robinson S, Stafstrom CE, Ferriero D, Gano D, Numis A, Gerner G, Scafidi J, Gilmore M, Allen MC, Hilberg M, Parkinson C. Chavez-Valdez R, et al. J Child Neurol. 2024 Jun;39(7-8):292-295. doi: 10.1177/08830738241259054. Epub 2024 May 31. J Child Neurol. 2024. PMID: 38819375 Free PMC article. No abstract available.